Evidence map›Paper›PMID 27986968›Full record

ArticleSexually transmitted infections2017

What explains anorectal chlamydia infection in women? Implications of a mathematical model for test and treatment strategies.

Janneke C M Heijne, Geneviève A F S van Liere, Christian J P A Hoebe, Johannes A Bogaards, Birgit H B van Benthem, Nicole H T M Dukers-Muijrers

Open access · bronzeAbstract read
In one paragraph

Article in Sexually transmitted infections, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Appraisal of the causal effect ofmedRxiv : the preprint server for health sciences · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. High Prevalence of RectalOpen forum infectious diseases · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. RectalInfection and drug resistance · 2021
    Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Janneke C M HeijneCentre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Geneviève A F S van LiereDepartment of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service, Geleen, Netherlands.
Christian J P A HoebeDepartment of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service, Geleen, Netherlands.
Johannes A BogaardsCentre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Birgit H B van BenthemCentre for Infectious Diseases Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Nicole H T M Dukers-MuijrersDepartment of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service, Geleen, Netherlands.
GGD Zuid Limburg · NLNational Institute for Public Health and the Environment · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesFemale anorectal

methodsWe developed a pair compartmental model of heterosexuals aged 15-29 years attending STI clinics, in which women can be susceptible to or infected with chlamydia urogenitally and/or anorectally and men urogenitally. Transmission probabilities per vaginal and anal sex act, together with an autoinoculation probability, were estimated by fitting to anatomic site-specific prevalence data (14% urogenital; 11% anorectal prevalence). We investigated the 10-year reduction in female chlamydia prevalence of interventions (universal anorectal testing of female STI clinic attendees or doxycycline use for urogenital chlamydia) relative to continued current care (anorectal testing on indication and doxycycline for anorectal and azithromycin for urogenital chlamydia).

resultsThe transmission probability per anal sex act was 5.8% (IQR 3.0-8.3%), per vaginal sex act 2.0% (IQR 1.7-2.2%) and the daily autoinoculation probability was 0.7% (IQR 0.5-1.0%). More anorectal chlamydia infections were caused by autoinoculation than by recent anal sex. Universal anorectal testing reduced population prevalence modestly with 8.7% (IQR 7.6-9.7%), yet the reduction was double that of doxycycline use for urogenital infections (4.3% (IQR 3.5-5.3%)) relative to continued current care.

conclusionsAutoinoculation between anatomic sites in women might play a role in sustaining high chlamydia prevalence. A shift to more anorectal testing of female STI clinic attendees may be considered for its (albeit modest) impact on reducing prevalence.

Indexed as

AdolescentAdultAmbulatory Care FacilitiesAnal CanalAnus DiseasesChlamydia InfectionsChlamydia trachomatisDoxycyclineFemaleHeterosexualityHumansModels, TheoreticalPrevalenceSexual BehaviorVaginaDoxycyclineANOGENITAL CONDITIONSCHLAMYDIA TRACHOMATISMATHEMATICAL MODELTREATMENTWOMEN

Identifiers

PMID27986968
PMCPMC5520248
OpenAlexW2566851405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.